Jitendra Singh Shailendra Vikram, Bachaspatimayum Romita, Devi A Subhalakshmi, Rita S
Postgraduate Student, Department of Pharmacology, Regional Institute of Medical Sciences, Imphal, Manipur, India.
Assistant Professor, Department of Dermatology, Venereology and Leprosy, Regional Institute of Medical Sciences, Imphal, Manipur, India.
J Clin Diagn Res. 2017 Aug;11(8):FD01-FD02. doi: 10.7860/JCDR/2017/26536.10499. Epub 2017 Aug 1.
Erythema Nodosum Leprosum (ENL) may have a chronic course which may be recalcitrant to treatment. Preferred treatment modalities are systemic corticosteroids and thalidomide. Azathioprine, methotrexate and cyclosporine are immunosuppressants which may also be used as a steroid sparing agent. We report the case of a 48-year-old male diagnosed as lepromatous leprosy that developed ENL after four months of Multibacillary Multi-Drug Therapy (MB-MDT). He was treated with oral prednisolone (1 mg/kg/day) which was gradually tapered upto a dose of 7.5 mg/day. He developed recurrences on and off once the dose reached the said level and this continued for three years. Oral clofazamine (300 mg/day x 6 months; then 100 mg/day x 6 months) was also added in the second year. Thalidomide (200 mg/day) was also given but withdrawn due to adverse effect after 10 days. Azathioprine was started at a dose of 100 mg/day following which there was resolution of symptoms by one week and no recurrences by 10 weeks; it was given for eight months after which the dose was tapered to 50 mg/day for another four months. Complete withdrawal of oral prednisolone after gradual tapering was possible by 12 months of azathioprine therapy. The patient is still on regular follow-up with no recurrences so far till the last check-up.
结节性红斑麻风(ENL)可能病程呈慢性,且治疗可能效果不佳。首选治疗方式为全身使用皮质类固醇和沙利度胺。硫唑嘌呤、甲氨蝶呤和环孢素是免疫抑制剂,也可用作类固醇节约剂。我们报告一例48岁男性病例,该患者被诊断为瘤型麻风,在接受多菌型联合化疗(MB-MDT)四个月后出现ENL。他接受口服泼尼松龙治疗(1毫克/千克/天),剂量逐渐减至7.5毫克/天。一旦剂量达到上述水平,病情就会反复,这种情况持续了三年。第二年还加用了口服氯法齐明(300毫克/天,共6个月;然后100毫克/天,共6个月)。也给予了沙利度胺(200毫克/天),但10天后因不良反应停药。开始使用硫唑嘌呤,剂量为100毫克/天,一周后症状缓解,10周后无复发;用药8个月后,剂量减至50毫克/天,再用4个月。硫唑嘌呤治疗12个月后,可逐渐减量并完全停用口服泼尼松龙。该患者仍在定期随访,直至最后一次检查,目前尚无复发。